9663484

Source:http://linkedlifedata.com/resource/pubmed/id/9663484

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0003873, umls-concept:C0021755, umls-concept:C0078058, umls-concept:C0302600, umls-concept:C1171892, umls-concept:C1456820, umls-concept:C1709059
pubmed:issue	7
pubmed:dateCreated	1998-7-22
pubmed:abstractText	To investigate the regulation of expression of the angiogenic cytokine vascular endothelial growth factor (VEGF) in rheumatoid arthritis (RA), in order to determine whether new blood vessel formation could be a potential therapeutic target in RA.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0370605
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/Endothelial Growth Factors, http://linkedlifedata.com/resource/pubmed/chemical/IL1RN protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Interleukin 1 Receptor Antagonist..., http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-1, http://linkedlifedata.com/resource/pubmed/chemical/Lymphokines, http://linkedlifedata.com/resource/pubmed/chemical/Methotrexate, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Interleukin-1, http://linkedlifedata.com/resource/pubmed/chemical/Sialoglycoproteins, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha, http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor A, http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factors
pubmed:status	MEDLINE
pubmed:month	Jul
pubmed:issn	0004-3591
pubmed:author	pubmed-author:FeldmannMM, pubmed-author:MainiR NRN, pubmed-author:McCloskeyR VRV, pubmed-author:PaleologE MEM, pubmed-author:StarkA CAC, pubmed-author:YoungSS
pubmed:issnType	Print
pubmed:volume	41
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1258-65
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:9663484-Antibodies, Monoclonal, pubmed-meshheading:9663484-Arthritis, Rheumatoid, pubmed-meshheading:9663484-Cell Hypoxia, pubmed-meshheading:9663484-Cells, Cultured, pubmed-meshheading:9663484-Dose-Response Relationship, Drug, pubmed-meshheading:9663484-Double-Blind Method, pubmed-meshheading:9663484-Endothelial Growth Factors, pubmed-meshheading:9663484-Enzyme-Linked Immunosorbent Assay, pubmed-meshheading:9663484-Gene Expression Regulation, pubmed-meshheading:9663484-Humans, pubmed-meshheading:9663484-Interleukin 1 Receptor Antagonist Protein, pubmed-meshheading:9663484-Interleukin-1, pubmed-meshheading:9663484-Lymphokines, pubmed-meshheading:9663484-Methotrexate, pubmed-meshheading:9663484-Receptors, Interleukin-1, pubmed-meshheading:9663484-Sialoglycoproteins, pubmed-meshheading:9663484-Synovial Membrane, pubmed-meshheading:9663484-Tumor Necrosis Factor-alpha, pubmed-meshheading:9663484-Vascular Endothelial Growth Factor A, pubmed-meshheading:9663484-Vascular Endothelial Growth Factors
pubmed:year	1998
pubmed:articleTitle	Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis.
pubmed:affiliation	Kennedy Institute of Rheumatology, London, UK.
pubmed:publicationType	Journal Article, Clinical Trial, Randomized Controlled Trial, Controlled Clinical Trial, Research Support, Non-U.S. Gov't, Multicenter Study